Daiichi Sankyo http://www.globalpost.com/taxonomy/term/35923/all en India's Ranbaxy surprises with quarterly loss http://www.globalpost.com/dispatch/news/afp/130226/indias-ranbaxy-surprises-quarterly-loss <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>India's largest drug firm Ranbaxy reported Tuesday a sharp narrowing of its quarterly net loss but missed analyst forecasts for a profit after it was hit by product recall charges.</p> <p>The generics drug maker, majority-owned by Japan's Daiichi Sankyo, posted a net loss of 4.92 billion rupees ($91 million) for the three months to December, down from a loss of 29.83 billion rupees a year earlier.</p> <p>But analysts had expected Ranbaxy to be in the black for the fourth quarter and report a net profit of around 2.2 billion rupees, according to a poll by Dow Jones Newswires.</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130226/indias-ranbaxy-surprises-quarterly-loss" target="_blank">read more</a></p> BSE Sensex Daiichi Sankyo Entertainment Ranbaxy Laboratories Ranbaxy Laboratories AFP Tue, 26 Feb 2013 16:16:11 +0000 Agence France-Presse 5767366 at http://www.globalpost.com Hashimoto clarifies remarks on "comfort women" after flak http://www.globalpost.com/dispatch/news/kyodo-news-international/130507/refiling-update1-japan-taiwan-end-joint-fishing-commit <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Kyodo News International </div> </div> </div> <!--paging_filter--><p> Osaka Mayor Toru Hashimoto on Wednesday sought to clarify his remarks on a system to recruit women into sexual servitude for Japan's soldiers during World War II, saying he personally does not condone the scheme.</p> <p> Two days after he made controversial remarks that the so-called comfort women were "necessary to maintain discipline" in the Japanese military, Hashimoto told reporters he simply stated a fact that people at the time had that kind of view.</p> <p><a href="http://www.globalpost.com/dispatch/news/kyodo-news-international/130507/refiling-update1-japan-taiwan-end-joint-fishing-commit" target="_blank">read more</a></p> Abe Arctic Ashwani Kumar Asia Awami National Party Barack Obama British knights BSE Sensex Business Carrier Strike Group Eleven Chemistry Corruption in India Crimes against humanity Cross-Strait relations Cruise ships Daiichi Sankyo Dance in Japan Divided regions Economic history Economics Economy of Japan Election fraud Elections Energy Energy conversion Environment Ethics Films Finance Financial planner Fiscal policy G-7 Gambling in Japan Geography of Asia Government Greenhouse gases Health Independent Commission Against Corruption Inflation International criminal law International economics International relations International trade Island countries Japan Japanese people Japan–United States relations Kim Jong-il Korea Kyushu region Labor Law Liberal democracies Liberal Democratic Party Macroeconomics Mass media Member states of the United Nations Memoirists Muslim League Muttahida Qaumi Movement North Korea North Korea North Korea–South Korea relations Nuclear physics Nuclear program of North Korea Nuclear technology Okinawa Prefecture Osaka Pakistan Pakistani politicians Physical geography Poetry Political geography Politics Politics of India Politics of Japan Politics of Pakistan Polling place Public finance Ranbaxy Laboratories Republics Secularism Secularism in Pakistan Senkaku Islands Shinzō Abe Shinzo Abe Social Issues Sōka Gakkai Taipei Taiwanese culture Taliban Technology Toru Hashimoto Tōru Hashimoto Trans-Pacific Partnership Unemployment United States trade policy USS Nimitz Volcanism War Yonhap Yoon Yoriko Kawaguchi YTN Group Kyodo News International Tue, 07 May 2013 16:30:16 +0000 Kyodo News International 5832850 at http://www.globalpost.com Japan's Daiichi says key details 'concealed' in Ranbaxy sale http://www.globalpost.com/dispatch/news/afp/130522/japans-daiichi-says-key-details-concealed-ranbaxy-sale <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>The Japanese owners of Ranbaxy on Wednesday accused former shareholders of the Indian company of concealing key information about a US probe into the safety of medicines made by the New Delhi-based firm.</p> <p>Last week, Ranbaxy Laboratories pleaded guilty in the United States to charges of making and distributing adulterated drugs at its two Indian plants of Paonta Sahib and Dewas and agreed to a $500 million settlement.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130522/japans-daiichi-says-key-details-concealed-ranbaxy-sale" target="_blank">read more</a></p> BSE Sensex Business Daiichi Sankyo Labor Law Ranbaxy Laboratories Ranbaxy Laboratories AFP Wed, 22 May 2013 19:30:16 +0000 Agence France-Presse 5844075 at http://www.globalpost.com Ranbaxy shares dive after Japan parent says was misled http://www.globalpost.com/dispatch/news/afp/130523/ranbaxy-shares-dive-after-japan-parent-says-was-misled <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Shares of Ranbaxy plunged Thursday after its Japanese parent accused former owners of the Indian firm of hiding key details about a US probe into the safety of drugs made by the generics giant.</p> <p>Last week, Ranbaxy Laboratories pleaded guilty in the United States to charges of making and distributing adulterated drugs at two Indian plants and agreed to a $500 million settlement.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130523/ranbaxy-shares-dive-after-japan-parent-says-was-misled" target="_blank">read more</a></p> BSE Sensex Business Daiichi Sankyo Labor Law Ranbaxy Laboratories Ranbaxy Laboratories AFP Thu, 23 May 2013 08:46:56 +0000 Agence France-Presse 5844494 at http://www.globalpost.com Japanese drugmakers open 'libraries' in $100 million health project http://www.globalpost.com/dispatch/news/thomson-reuters/130530/japanese-drugmakers-open-libraries-100-million-health-project <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>LONDON (Reuters) - Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientists hunting new treatments for malaria, tuberculosis and other diseases affecting the world's poor.</p> <p>The initiative, announced on Thursday, is the first project under a new $100 million partnership between the drugmakers, the Japanese government and the Bill &amp; Melinda Gates Foundation to fund research into neglected tropical diseases.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130530/japanese-drugmakers-open-libraries-100-million-health-project" target="_blank">read more</a></p> Daiichi Sankyo Economy of Japan Eisai Technology Thomson Reuters Thu, 30 May 2013 19:33:53 +0000 Thomson Reuters 5849021 at http://www.globalpost.com More pain for Japan's Daiichi hit by Ranbaxy fraud http://www.globalpost.com/dispatch/news/afp/130609/more-pain-japans-daiichi-hit-ranbaxy-fraud <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Daiichi Sankyo believed it had scored a coup in 2008 when it outbid rivals to buy Indian generics giant Ranbaxy for $4.6 billion but its foray into the high-growth copycat drugs arena has brought the Japanese drugmaker only pain.</p> <p>Last month, Ranbaxy pleaded guilty to US charges of selling adulterated antibiotic, acne, epilepsy and other drugs and agreed to a record $500-million fine, and since then the bad news has kept on flowing.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130609/more-pain-japans-daiichi-hit-ranbaxy-fraud" target="_blank">read more</a></p> BSE Sensex Business Daiichi Sankyo Hospitality Labor Law Politics Ranbaxy Ranbaxy Laboratories Social Issues AFP Sun, 09 Jun 2013 04:44:42 +0000 Agence France-Presse 5853390 at http://www.globalpost.com Indian drugmaker Ranbaxy faces new US regulation woes http://www.globalpost.com/dispatch/news/afp/130916/indian-drugmaker-ranbaxy-faces-new-us-regulation-woes <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Shares in Indian generic drugs giant Ranbaxy Laboratories crashed as much as 35 percent in early trade on Monday after the US Food and Drug Administration suspended imports from one of its factories.</p> <p>Ranbaxy slid to 297.25 rupees on the Bombay Stock Exchange, down 34.99 percent, before recovering to 341.00 rupees, down 25.42 percent.</p> <p>The FDA issued an alert on Friday against a Ranbaxy factory in Mohali in the northern state of Punjab, meaning imports are suspended from the plant.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130916/indian-drugmaker-ranbaxy-faces-new-us-regulation-woes" target="_blank">read more</a></p> BSE Sensex Business Daiichi Sankyo Health Labor Law Ranbaxy Laboratories Social Issues AFP Mon, 16 Sep 2013 06:49:12 +0000 Agence France-Presse 5935292 at http://www.globalpost.com Taiwan urges locals to stop using Daiichi Sankyo cosmetics http://www.globalpost.com/dispatch/news/kyodo-news-international/131205/taiwan-urges-locals-stop-using-daiichi-sankyo-cosmetic <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Kyodo News International </div> </div> </div> <!--paging_filter--><p> Taiwan's health authorities on Thursday urged consumers to stop using a line of skincare products of Japan's Daiichi Sankyo Healthcare Co. in the wake of complaints of swollen or itchy skin by Japanese users.</p> <p> The Tokyo-based company said earlier in the day that more than 270 users of "Derma Energy" series of skincare cosmetics reported problems to physicians.</p> <p> Taiwan's Ministry of Health and Welfare said in a statement that the products in question are not imported into Taiwan.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p>Copyright 2013 Kyodo News International.</p> <p>All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.</p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/kyodo-news-international/131205/taiwan-urges-locals-stop-using-daiichi-sankyo-cosmetic" target="_blank">read more</a></p> Daiichi Sankyo Health Labor Social Issues Technology Kyodo News International Thu, 05 Dec 2013 12:32:55 +0000 Kyodo News International 6010019 at http://www.globalpost.com India's Ranbaxy slumps, Sun Pharma surges on $3.2-billion acquisition http://www.globalpost.com/dispatch/news/thomson-reuters/140407/indias-ranbaxy-slumps-sun-pharma-surges-32-billion-acquisition <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>MUMBAI (Reuters) - Shares in India's Ranbaxy Laboratories Ltd &lt;RANB.NS&gt; fell as much as 3.2 percent on profit-taking after Sun Pharmaceutical Industries Ltd &lt;SUN.NS&gt; said it will buy the company in a $3.2 billion all-share deal, creating the world's fifth-largest generic drug maker.</p> <p>Ranbaxy shares had surged 32.6 percent in six consecutive sessions of gains till Friday's close.</p> <p>Sun Pharmaceutical shares rose as much as 4 percent.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2014.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/140407/indias-ranbaxy-slumps-sun-pharma-surges-32-billion-acquisition" target="_blank">read more</a></p> BSE Sensex Business Daiichi Sankyo Ranbaxy Laboratories Thomson Reuters Mon, 07 Apr 2014 09:47:51 +0000 Thomson Reuters 6114960 at http://www.globalpost.com Tokyo shares end 1.69% lower http://www.globalpost.com/dispatch/news/afp/140407/tokyo-shares-end-169-lower <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Tokyo stocks fell 1.69 percent Monday following a heavy sell-off on Wall Street, while the yen strengthened against the dollar, denting exporter shares.</p> <p>The benchmark Nikkei-225 index lost 254.92 points to finish at 14,808.85, while the Topix index of all first-section issues fell 1.57 percent, or 19.05 points, to 1,196.84.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2014.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/140407/tokyo-shares-end-169-lower" target="_blank">read more</a></p> Daiichi Sankyo Economy of Japan Japanese yen Labor AFP Mon, 07 Apr 2014 10:03:18 +0000 Agence France-Presse 6114986 at http://www.globalpost.com